Martha Gaines, MD, JD, LLM, founder and director of The Center for Patient Partnerships, clinical professor of law, University of Wisconsin Law School, explains how The Center for Patient Partnerships helps patients understand their disease, identify their treatment options, and recognize resources available to them.
Martha Gaines, MD, JD, LLM, founder and director of The Center for Patient Partnerships, clinical professor of law, University of Wisconsin Law School, explains how The Center for Patient Partnerships helps patients understand their disease, identify their treatment options, and recognize resources available to them.
Transcript
How does The Center for Patient Partnerships help patients understand their disease, identify their treatment options, and recognize resources available to them?
The first thing we do when a patient calls us and says, “Help. I’ve been diagnosed with something I can’t even pronounce, much less do I know what to do about it or who to go see,” is listen, learn about the patient. Almost immediately you will hear the kinds of barriers that are up for patients: “I don’t know how to learn more” or “I’m having an issue with my clinician.” You can learn that very quickly.
You also learn what kind of skills the patient already has inside them. If you’ve been a school teacher, if you’ve been a homeless person, if you’ve been a mother. You have certain skill sets that are easily transferrable to healthcare, but patients always assume it’s a foreign country with a foreign language and I’m completely bamboozled. But, it doesn’t have to be that way, because it’s not a foreign country, and the foreign language is not that hard to learn. Besides, there are a lot of interpreters and translators.
So, really, what we do is listen to people, identify the issues, and then help them either find a good place for their care. We also work with financial issues, and then we also help people talk with their employers. Very often, employers will say you can take whatever time you need, it’s all god. But, after 4 or 5 months of chemotherapy, the employers didn’t really know what they were saying it, turns out. So, then that gets awkward and difficult and sometimes people lose their jobs. At the very least, there’s a lot of feelings hurt, a lot bridges sort of broken. So, we help people negotiate right up front with their employers and be very clear about what it’s going to take and hopefully keep those relationships intact.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More